Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A case report
Article in Thoracic Cancer (July 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Thoracic Cancer (July 2024)
Article in Cancers (April 2024)
Preprint in Research Square (March 2024)